Verrucous carcinoma staging

Revision as of 15:48, 11 September 2012 by Vishnu Vardhan Serla (talk | contribs)
Jump to navigation Jump to search

Verrucous carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Verrucous carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Verrucous carcinoma staging On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Verrucous carcinoma staging

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Verrucous carcinoma staging

CDC on Verrucous carcinoma staging

Verrucous carcinoma staging in the news

Blogs on Verrucous carcinoma staging

Directions to Hospitals Treating Verrucous carcinoma

Risk calculators and risk factors for Verrucous carcinoma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Most verrucous carcinomas are nonmetastatic and are staged based on size, as follows:

  • T0 lesions - In situ
  • T1 lesions - Less than 2 cm in diameter
  • T2 lesions - Between 2 and 4 cm in diameter
  • T3 lesions - Greater than 4 cm in diameter
  • T4 lesions - Invasive of muscle or bone

References

Template:WH Template:WS